Loading...
LENSAR, Inc.
LNSR•NASDAQ
Healthcare
Medical - Devices
$13.05
$0.12(0.93%)
LENSAR, Inc. (LNSR) Company Profile & Overview
Explore LENSAR, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
LENSAR, Inc. (LNSR) Company Profile & Overview
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
SectorHealthcare
IndustryMedical - Devices
CEONicholas T. Curtis
Contact Information
Company Facts
140 Employees
IPO DateOct 2, 2020
CountryUS
Actively Trading